The Domperidone Problem – The Goldwater Institute tells the story

Domperidone is a drug that has been used to treat patients with gastroparesis. It is not available by prescription in the United States, and while it was once able to be formulated in compounding pharmacies, that practice has been banned by the FDA. Domperidone is also available in many other countries, including Canada, but the FDA has blocked those channels for acquiring the drug as well.

Why is such a successful medication being targeted by the FDA?

The Goldwater Institute’s Mark Flatten has, with cooperation from G-PACT, written a powerful article explaining the many problems patients face getting access to Domperidone, titled, SICKENING: FDA BUREAUCRACY BLOCKS COMMON “MIRACLE DRUG”

We encourage you to read it. Then we encourage you to take action with your legislative representatives.

Learn more about Domperidone from The Mayo Clinic, here.

See what the Food and Drug Administration have to say about Domperidone and how to get it, here.